3 COVID-19 'suspects' in Palawan dead | Inquirer News

3 COVID-19 ‘suspects’ in Palawan dead

By: - Correspondent / @RVMirandaINQ
/ 01:38 PM May 21, 2020

PUERTO PRINCESA CITY –– Three patients suspected to have the coronavirus disease (COVID-19) have died in Palawan, bringing the total number of casualties in the province to 38.

Richard Ligad, chief of City Information Office, in a Facebook announcement late Wednesday, said that of the three deceased suspected COVID-19 patients, one was from an urban barangay in Puerto Princesa City.

The patient was a 50 to 55-year-old male, who was already swabbed and is pending test result. He was also known to have other co-morbidities, according to Ligad.

Article continues after this advertisement

The profiles of the other two deceased patients were yet to be disclosed.

Palawan is monitoring a total of 64 COVID-19 patients, 56 of whom are considered suspects, while eight are considered probable cases based on the bulletin issued by the Center for Health Development-Mimaropa as of 3 p.m. Wednesday.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, Palawan, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.